FDA Inspection 845620 — Carter BloodCare - Rosedale
The FDA completed an inspection of Carter BloodCare - Rosedale on Aug 23, 2013 in Fort Worth, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 23, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fort Worth, TX (United States)